NCIRS: Final data show suboptimal influenza vaccine coverage in 2025
The National Centre for Immunisation Research and Surveillance (NCIRS) has released its final influenza vaccination coverage data for 2025.
The data shows that influenza uptake is suboptimal across all age cohorts.
- The 50-to-64-years and 65-years-and-older groups had the lowest vaccination rates in six years.
- The 6-months-to-4-years group had the lowest rates since 2021.
- The 15-to-49-years and 5-to-14 years groups both recorded slightly higher rates than 2024, but lower than previous years.
2025 influenza vaccine coverage data is available via the NCIRS website.
For more information on influenza disease and immunisation, go to MVEC: Influenza
Recording available now for members: CVU mini pneumococcal update (webinar)
A recording of last week’s CVU mini webinar is now available for Education Portal members.
Featuring Prof Nigel Crawford, Ms Rachael McGuire and Dr Linny Kimly Phuong, hear the latest on pneumococcal vaccination in line with the 1 September 2025 changes to the childhood pneumococcal vaccine schedule, followed by a brief Q&A session.
By becoming an Education Portal member, you not only support MVEC, but you get exclusive access to:
- past webinar recordings
- eLearnings
- special ticket prices for face-to-face MVEC events.
If you’re not already a member, why not become one now?
Updated immunisation reference page: Needle anxiety and phobia
MVEC has recently updated our reference page on needle anxiety and phobia. The updated reference page provides recommendations for managing needle anxiety and needle phobia across age groups.
This reference page is intended to be helpful for for individuals experiencing needle anxiety or needle phobia, caregivers/parents/support people for individuals who need support, and vaccine providers.
MVEC: Needle anxiety and phobia
Updated immunisation reference page: Solid organ transplant recipient: pre-transplant immunisation recommendations
MVEC has recently reviewed and updated our solid organ transplant recipient immunisation guidelines.
The updated reference page includes background information on this group, recommendations for serology and screening, and detailed guidelines for vaccinations and timing.
MVEC: Solid organ transplant recipient: pre-transplant immunisation recommendations
ACIP: US changes to vaccine guidance and recommendations
The American Advisory Committee on Immunization Practices (ACIP) met recently, voting to change MMRV and COVID-19 vaccine guidelines and recommendations, and postponing a vote on proposed changes to hepatitis B vaccination.
The combination measles, mumps, rubella and varicella vaccine (MMRV) is no longer recommended in the US for children under 4 years of age. The COVID-19 vaccine is no longer recommended for all adults in the US; recommendations are now subject to a ‘shared decision-making’ process whereby individuals are advised to weigh up risks and benefits with a healthcare professional.
Via our social media platforms, MVEC has published a shortform explainer (@mvecau on Instagram) on ACIP’s MMRV change and why it shouldn’t impact confidence in Australia’s immunisation program.
Materials from the 18 to 19 September meeting are not yet fully accessible for all audiences.
The following articles from US-based publications offer more context on the ACIP meeting:
NPR: CDC advisers punt on hepatitis B vaccine vote, after changing guidance on MMRV
ABC News: Why doctors say the birth dose of the hepatitis B vaccine is still necessary
For more information on the relevant vaccine-preventable diseases, go to:
MVEC: Measles
MVEC: Varicella
MVEC: COVID-19
MVEC: Hepatitis B
States offering nasal spray influenza vaccine in 2026
New South Wales, Queensland and South Australia have announced free nasal spray influenza vaccine programs for young children. Already widely used overseas, the FluMist intranasal vaccine is undergoing regulatory approval in Australia ahead of next year’s flu season.
The state programs will cover children aged between 2 and 5 years. The regular injectable influenza vaccine remains free nationwide for all children aged 6 months to < 5 years.
Read more on each state program here:
New South Wales: Free nasal spray influenza vaccine for children under five
Queensland: 2026 Queensland Nasal Spray Flu Immunisation Program
South Australia: Needle-free flu vaccine for SA children
Read more about influenza disease and immunisation at MVEC: Influenza
NEJM: Clesrovimab for prevention of RSV disease in healthy infants
A recent trial has shown that a single dose of the monoclonal antibody clesrovimab reduced the incidence of RSV-associated lower respiratory infection and RSV-associated hospitalisation in healthy preterm and full-term infants.
Clesrovimab demonstrated 60% efficacy in reducing medically attended RSV-associated lower respiratory infection and 84% efficacy in reducing RSV-associated hospitalisation. The adverse-event profile of clesrovimab was similar to that of placebo. The authors note that rare serious adverse events may not be detected in a trial of this size (3632 infants).
Read the paper in full: NEJM: Clesrovimab for prevention of RSV disease in healthy infants
Read more about respiratory syncytial virus (RSV) at MVEC: RSV
New York Times: The playbook used to ‘prove’ vaccines cause autism
The New York Times recently published an essay written by public health expert and science communicator Dr Jess Steier. Focusing on the work of vaccine critic David Geier, Dr Steier breaks down the “anti-vaccine research playbook” to help people spot flawed science.
Read the article in full at NYT: The playbook used to ‘prove’ vaccines cause autism
Read more on autism and vaccination on MVEC: Autism and immunisation
Registrations now open: 16th Australian Influenza Symposium, 2025
The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is holding the 16th Australian Influenza Symposium (AIS) on 13 to 14 November 2025. Limited places are available. Registrations will close on 3 November 2025.
Date: 13–14 November 2025
Venue: Doherty Institute Auditorium, Melbourne
Learn more and register on the AIS event page.
Victorian Department of Health: New measles alert
The Victorian Department of Health has issued a new health alert following a new measles case in Victoria. The alert includes an up-to-date list of public exposure sites in Victoria.
Read the alert in full at the department’s page Health alerts: New measles case in Victoria.
Learn more about measles disease and vaccination at MVEC: Measles
And check out MVEC director Prof Nigel Crawford’s May 2025 Healthed article and podcast, which both cover the current measles resurgence.